News
Nemolizumab continues to crush itch in 64-week atopic dermatitis study
GENEVA – But anti-interleukin-31 receptor A antibody may need topical help to get optimal dermatitis drop.
News
Top research to be presented at AAGL
Dr. Charles E. Miller offers his top picks for research presentations at the 2017 AAGL Global Congress.
News
Case study suggests maternal inheritance of PBC susceptibility
Screening with antimitochondrial-antibody and liver-function tests should be recommended to other family members for early detection and...
Article
Does Anyone Really Understand Nutrition Labels?
Study shows that most people are either unable to read or follow nutrition labels, causing an increase in overeating.
News
FDA approves first treatment for ECD
The US Food and Drug Administration (FDA) has expanded the approved use of vemurafenib (Zelboraf) to include the treatment of adults who have...
News
Ibrutinib sustains efficacy in CLL at 4-year follow-up
NEW YORK, NY—The 4-year follow-up of the RESONATE trial suggests ibrutinib may provide long-term efficacy in previously treated patients with...
News
FDA approves wider use of hematology analyzer
The US Food and Drug Administration (FDA) has expanded the approved use of the XW-100 Automated Hematology Analyzer. The analyzer can now be used...
News
Intervention improves well-being in AYAs with cancer
SAN DIEGO—New research suggests an intervention can improve psychosocial health in adolescents and young adults (AYAs) living with cancer. The...
News
Rates, predictors, and variability of interhospital transfers
Clinical question: What is the national frequency of interhospital transfers, and are there any patient or hospital factors that...
Article
Insulin Pump Therapy: Who, Why, and How
Diabetes management is moving beyond metformin, thanks to new and advancing technology. Here's your guide to insulin pumps: what they do, who...